Medical Program

Cannabis for Medical Conditions in Minnesota (2026)

Minnesota's medical cannabis program covers 19 qualifying conditions - from chronic pain and PTSD to anxiety, insomnia, and cancer. The state fee is $0. Here's everything you need to know about getting your card, which products work for each condition, and why a medical card still has real advantages even with recreational cannabis legal.

Why Get a Medical Card in 2026?

$0 state fee
Just the doctor consult ($75-149)
6 oz in public
vs 2 oz for recreational users
Ages 18-20
Medical card bridges the age gap
Tax advantages
Potential savings at some dispensaries

Common Medical Uses

Chronic Pain

THC and CBD combinations for long-term pain management

Anxiety & PTSD

High-CBD products and balanced ratios for mental health

Sleep & Insomnia

CBN + THC formulations designed for deep, restful sleep

Inflammation

Anti-inflammatory cannabinoids for arthritis and autoimmune conditions

Qualifying Conditions

Minnesota recognizes 19 conditions for the medical cannabis program. A licensed healthcare practitioner must certify your condition before you can register with the state.

Cancer (severe treatment symptoms)
Glaucoma
HIV/AIDS
Tourette Syndrome
ALS
Seizures & Epilepsy
Severe Muscle Spasms
Crohn's Disease
Terminal Illness
Intractable Pain
PTSD
Autism Spectrum Disorder
Sickle Cell Disease
Obstructive Sleep Apnea
Alzheimer's Disease
Anxiety Disorder
Depression
Insomnia
Chronic Pain

Source: Minnesota Office of Cannabis Management. Conditions may be updated by legislative session.

Medical Cannabis Guides & Articles

12 articles
Cannabis for Epilepsy and Seizures in Minnesota: A 2026 Guide to CBD, Epidiolex, and Drug Interactions
Medical

Cannabis for Epilepsy and Seizures in Minnesota: A 2026 Guide to CBD, Epidiolex, and Drug Interactions

Approximately 60,000 Minnesotans live with epilepsy and one in three has treatment-resistant seizures. Here is what the clinical evidence says about CBD for seizures, how Epidiolex compares to dispensary products, critical drug interactions with anti-epileptic medications, and how to qualify for the medical cannabis program.

Feb 25, 2026
Cannabis for Migraines in Minnesota: A 2026 Guide to Relief, Prevention, and Drug Interactions
Medical

Cannabis for Migraines in Minnesota: A 2026 Guide to Relief, Prevention, and Drug Interactions

Migraines affect roughly 850,000 Minnesotans. Here is what clinical research says about cannabis for acute migraine relief and prevention, including drug interactions with triptans, beta-blockers, topiramate, and valproate, and how to qualify for the medical cannabis program.

Feb 25, 2026
Cannabis for Parkinson's Disease in Minnesota: A 2026 Guide to Tremors, Sleep, and Drug Interactions
Medical

Cannabis for Parkinson's Disease in Minnesota: A 2026 Guide to Tremors, Sleep, and Drug Interactions

Parkinson's disease is an explicit qualifying condition for Minnesota's medical cannabis program. This 2026 guide covers the clinical evidence for tremor, REM Sleep Behavior Disorder, and pain, along with critical drug interactions with levodopa, MAO-B inhibitors, and dopamine agonists — and why CBD-dominant products are the safest starting point for most Parkinson's patients.

Feb 25, 2026
Cannabis for Arthritis in Minnesota: A 2026 Guide to Joint Pain, Inflammation, and OA vs. RA
Medical

Cannabis for Arthritis in Minnesota: A 2026 Guide to Joint Pain, Inflammation, and OA vs. RA

Osteoarthritis and rheumatoid arthritis involve different mechanisms and respond differently to cannabis. This 2026 guide covers the endocannabinoid system in joint tissue, clinical evidence, drug interactions with methotrexate and JAK inhibitors, product recommendations by arthritis type, and how Minnesota patients can qualify for a medical card.

Feb 25, 2026
Cannabis for Fibromyalgia in Minnesota: A 2026 Guide to Pain, Sleep, and Fibro Fog
Medical

Cannabis for Fibromyalgia in Minnesota: A 2026 Guide to Pain, Sleep, and Fibro Fog

Fibromyalgia affects millions of Americans, and a growing body of research suggests CBD-dominant cannabis can help manage widespread pain, sleep disruption, and fibro fog. Here is what Minnesota fibromyalgia patients need to know about qualifying for the medical program, choosing products, and navigating drug interactions with Lyrica, Cymbalta, and tramadol.

Feb 25, 2026
Cannabis for Sleep and Insomnia in Minnesota: A 2026 Evidence-Based Guide
Medical

Cannabis for Sleep and Insomnia in Minnesota: A 2026 Evidence-Based Guide

Sleep problems are the most common reason Minnesotans visit a dispensary. Here is what the clinical evidence actually shows about THC, CBD, and CBN for insomnia, plus drug interactions and which qualifying conditions apply in Minnesota.

Feb 25, 2026
Cannabis for Multiple Sclerosis in Minnesota: A 2026 Guide to Spasticity, Pain, and Symptom Relief
Medical

Cannabis for Multiple Sclerosis in Minnesota: A 2026 Guide to Spasticity, Pain, and Symptom Relief

Multiple sclerosis is a qualifying condition for the Minnesota medical cannabis program. This guide covers what the evidence shows for spasticity, neuropathic pain, and bladder symptoms, plus drug interactions with common MS medications and how to use the medical card for tax savings.

Feb 24, 2026
Cannabis for IBS in Minnesota: A 2026 Guide to Irritable Bowel Syndrome Relief
Medical

Cannabis for IBS in Minnesota: A 2026 Guide to Irritable Bowel Syndrome Relief

Irritable bowel syndrome is an official Minnesota medical cannabis qualifying condition. Learn what the research says, which products work best for IBS-D and IBS-C, and how to get your medical card for 22% tax savings.

Feb 24, 2026
Cannabis for Cancer Patients in Minnesota: A 2026 Guide to Symptom Relief
Medical

Cannabis for Cancer Patients in Minnesota: A 2026 Guide to Symptom Relief

Cancer is a Minnesota medical cannabis qualifying condition. This guide covers the strongest evidence for cannabis in chemotherapy-induced nausea, appetite loss, and cancer pain — plus the drug interactions every oncology patient needs to know before visiting a Minnesota dispensary.

Feb 24, 2026
Cannabis and ADHD in Minnesota: What the Research Says in 2026
Medical

Cannabis and ADHD in Minnesota: What the Research Says in 2026

Many adults with ADHD turn to cannabis for symptom relief, but what does the research actually show? This guide covers ECS-ADHD biology, drug interactions with stimulants and Strattera, whether ADHD qualifies for a Minnesota medical card, and evidence-based guidance for adults considering cannabis.

Feb 24, 2026
Cannabis for Seniors in Minnesota: A Complete 2026 Guide for Older Adults
Medical

Cannabis for Seniors in Minnesota: A Complete 2026 Guide for Older Adults

Adults 65 and older are the fastest-growing cannabis consumer segment. This guide covers how aging changes your cannabis experience, the strongest evidence for chronic pain, arthritis, sleep, and anxiety, drug interactions seniors must know (warfarin, blood thinners, sedatives), best product types, dosing guidance, Minnesota qualifying conditions for a medical card, and how to navigate a dispensary for the first time.

Feb 24, 2026
Cannabis and Depression in Minnesota: What the Research Shows in 2026
Medical

Cannabis and Depression in Minnesota: What the Research Shows in 2026

Depression affects millions of Minnesotans. This research-backed guide covers the endocannabinoid system's role in mood, what clinical studies actually show, how CBD and THC differ, drug interactions with antidepressants, and practical guidance for consumers in 2026.

Feb 24, 2026

Ready to get your medical card?

Step-by-step guide - from finding a telemedicine provider to receiving your card.

Get Your Card

Frequently Asked Questions - Medical Cannabis Minnesota